Manufacturing review: a manufacturing review was performed.The lot records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.The review shows that no remarkable incidents occurred during the manufacturing process.No relevant manufacturing process changes were implemented, that could have led to the event reported.No additional complaint has been reported for this lot number previously.Investigation summary: as part of all complaint investigations, an attempt was made to evaluate the subject device as well as the device usage.In this particular case no sample and no images were provided for evaluation, therefore the investigation is closed with inconclusive results.Potential factors which may have cause or contributed to the reported issue have been considered.The reported application presents an off label use of the device.However, based on the information available and as no sample was returned, a definite root cause could not be identified.Labeling review: in reviewing the labeling supplied with this product it was found that the instructions for use (ifu) sufficiently address the potential risk.The ifu states: "examine the packaging and endovascular system to determine if there is any damage, defects or if the sterile barrier is compromised.Do not use the device if any of these conditions are observed." based on ifu supplied with this product the fluency® plus endovascular stent graft is indicated for use in the treatment of in-stent restenosis in the venous outflow of hemodialysis patients dialyzing (.) and for the treatment of stenosis in the venous outflow of hemodialysis patients dialyzing by an av graft.The reported application to cover an extravasation presents an off label use of the device.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
|
It was reported that a stent graft was deployed to cover up an extravasation and the stent graft covered the perforation.However, an alleged leak was still identified at the perforation site.It was alleged by the customer that there was a tear in the coating in the middle of the stent graft allowing the extravasation to continue.It was further reported that another stent graft was deployed inside the previous stent graft, overlapping technique, and resolved the perforation.There was no reported patient injury.
|